Riddle et al developed a schedule for titrating insulin doses in type 2 diabetic that would achieve a given target fasting plasma glucose ("treat-to-target"). This can result in effective insulin therapy while minimizing the risk of adverse side effects. The authors are from the Insulin Glargine 4002 Study Investigators.

To read more or access our algorithms and calculators, please log in or register.